Physician
Central Washington Sleep Diagnostic Center, PLLC
Central Washington Sleep Diagnostic Center, PLLC was paid $6.90M by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 62% of everything it billed.
33Billing provider infoCENTRAL WASHINGTON SLEEP DIAGNOSTIC CENTER, PLLC
MOSES LAKE, WA 98837
MOSES LAKE, WA 98837
33aNPI1558685925assigned 03/15/2010
33bProvider typeAddiction Medicine (Family Medicine) Physician
28Total paid$6.90M
24GClaims102,212
24DCodes billed32
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Addiction Medicine (Family Medicine) Physician providers in Washington
Rank by total paid#1 of 10
Median peer was paid$960K
This provider vs. median7.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 510 | $25K | |
| 2019 | 12,368 | $926K | |
| 2020 | 22,259 | $1.32M | |
| 2021 | 17,341 | $1.14M | |
| 2022 | 18,792 | $1.42M | |
| 2023 | 17,721 | $1.21M | |
| 2024incomplete | 13,221 | $868K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 62% | 50,502 | 34,244 | $4.29M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.1% | 5,931 | 3,865 | $350K |
| E0601 | Continuous positive airway pressure (cpap) device | 5.0% | 1,814 | 1,783 | $344K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.5% | 3,236 | 3,147 | $308K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 3.8% | 1,823 | 1,648 | $260K |
| 95811 | 2.8% | 597 | 587 | $193K | |
| A7034 | Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap | 1.7% | 1,352 | 1,196 | $121K |
| A4604 | Tubing with integrated heating element for use with positive airway pressure device | 1.7% | 2,115 | 1,951 | $119K |
| A7030 | Full face mask used with positive airway pressure device, each | 1.6% | 707 | 691 | $109K |
| A7038 | Filter, disposable, used with positive airway pressure device | 1.5% | 10,691 | 10,488 | $103K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.5% | 695 | 607 | $101K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.3% | 1,664 | 1,315 | $91K |
20 more codes
| A7035 | Headgear used with positive airway pressure device | 1.1% | 2,269 | $79K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 190 | $67K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 412 | $59K |
| A7032 | Cushion for use on nasal mask interface, replacement only, each | <1% | 1,270 | $45K |
| A7031 | Face mask interface, replacement for full face mask, each | <1% | 786 | $41K |
| 84703 | <1% | 5,184 | $33K | |
| Q3014 | Telehealth originating site facility fee | <1% | 1,570 | $31K |
| E0562 | Humidifier, heated, used with positive airway pressure device | <1% | 109 | $28K |
| A7046 | Water chamber for humidifier, used with positive airway pressure device, replacement, each | <1% | 2,208 | $28K |
| 99205 | Prolong outpt/office vis | <1% | 159 | $28K |
| A7039 | Filter, non disposable, used with positive airway pressure device | <1% | 1,896 | $26K |
| A7036 | Chinstrap used with positive airway pressure device | <1% | 1,226 | $20K |
| 80305 | <1% | 1,001 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,287 | $10K |
| 95806 | <1% | 70 | $3K | |
| A7037 | Tubing used with positive airway pressure device | <1% | 81 | $3K |
| 99354 | <1% | 32 | $2K | |
| 99457 | <1% | 1,307 | $1K | |
| 99442 | <1% | 16 | $639.00 | |
| A7033 | Pillow for use on nasal cannula type interface, replacement only, pair | <1% | 12 | $216.07 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAEGER, ERIC (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Central Washington Sleep Diagnostic Center, PLLC | Wenatchee, WA | $2.30M |
| Central Washington Sleep Diagnostic Center, PLLC | Brewster, WA | $1.23M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.